# GLOBEIMMUNE INC: Form D filings

GLOBEIMMUNE INC, a pharmaceuticals company in Louisville, CO, filed 8 Form D notices with the SEC between 2009 and 2017. The latest, on March 23, 2017, reports $2.1 million sold of a $2.1 million offering to 1 investor.

Find out what GLOBEIMMUNE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GLOBEIMMUNE%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GLOBEIMMUNE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fglobeimmune-inc-1245104)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GLOBEIMMUNE%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GLOBEIMMUNE%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fglobeimmune-inc-1245104)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1450 INFINITE DRIVE, Louisville, CO, 80027
- Phone: (303) 625-2744
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1245104

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 23, 2017 | New notice | $2,100,000 | $2,100,000 | $0 | 1 | Mar 20, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510417000002/0001245104-17-000002-index.htm) |
| Jun 10, 2014 | Amendment | $7,500,000 | $7,500,000 | $0 | 110 | Jan 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510414000003/0001245104-14-000003-index.htm) |
| Mar 12, 2014 | New notice | $391,730 | $391,730 | $0 | 1 | Nov 12, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510414000002/0001245104-14-000002-index.htm) |
| Feb 13, 2014 | New notice | $7,500,000 | $7,500,000 | $0 | 92 | Jan 31, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510414000001/0001245104-14-000001-index.htm) |
| Feb 3, 2010 | Amendment | $17,999,124 | $17,999,124 | $0 | 27 | Jan 14, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510410000002/0001245104-10-000002-index.htm) |
| Jan 27, 2010 | New notice | $17,999,124 | $17,507,816 | $491,308 | 26 | Jan 14, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510410000001/0001245104-10-000001-index.htm) |
| May 20, 2009 | New notice | $13,000,000 | $13,000,000 | $0 | 1 | May 14, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510409000004/0001245104-09-000004-index.htm) |
| Mar 17, 2009 | New notice | $5,000,000 | $2,564,710 | $2,435,290 | 17 | Mar 3, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1245104/000124510409000003/0001245104-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Charles Jeffrey Kim | Director |  |
| C. Jeffrey Dekker | Executive Officer |  |
| Jerel Jeffrey Banks | Director |  |
| Timothy C. Rodell | Director |  |

[Every Form D from the week of Mar 20, 2017](https://specstream.ai/data/form-d/week/2017-03-20) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what GLOBEIMMUNE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).